Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01783288 · ClinicalTrials.gov registry record · NA
Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening
A NA study of Postural Tachycardia Syndrome, sponsored by Vanderbilt University.
- Active
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT01783288 is a NA study of Postural Tachycardia Syndrome that is active but no longer recruiting, run by Vanderbilt University. The registered enrollment target is 110 participants, above the 77-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (43% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01783288, a NA study of Postural Tachycardia Syndrome, is active but no longer recruiting, sponsored by Vanderbilt University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether patients meet criteria for Postural Tachycardia Syndrome (or not) and have reduced blood volume (or not). Both of these are important screening elements to Aim 3 of a National Institutes of Health Grant. The purposes of Aim 3 are to determine 1. whether a high dietary sodium level appropriately expands plasma volume in Postural Orthostatic Tachycardia, 2. whether plasma renin activity and aldosterone are modified appropriately by changes in dietary sodium in Postural Tachycardia Syndrome and 3. whether patients with Postural Tachycardia Syndrome have improvements in their orthostatic tachycardia and symptoms as a result of a high dietary sodium level.
Conditions Studied
Interventions
- OTHER Autonomic Function Testing
- OTHER Posture Study
- PROCEDURE Measurement of Total Blood Volume
- OTHER Exercise Capacity Test
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2013-02 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01783288
The ClinicalTrials.gov registry entry for NCT01783288 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 77-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (43% higher). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 4 interventions - of which Autonomic Function Testing is the first listed.
NCT01783288 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT01783288 about?
NCT01783288 is a clinical study titled "Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening". The purpose of the study is to determine whether patients meet criteria for Postural Tachycardia Syndrome (or not) and have reduced blood volume (or not). Both of these are important screening elements to Aim 3 of a National Institutes of Health Grant. The purposes of Aim 3 are to determine 1. wheth...
What is the current status of trial NCT01783288?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2013-02. Estimated completion is 2026-12.
What conditions does trial NCT01783288 study?
This clinical trial studies the following conditions: Postural Tachycardia Syndrome.
What interventions are being tested in trial NCT01783288?
The interventions under investigation include: Autonomic Function Testing (OTHER), Posture Study (OTHER), Measurement of Total Blood Volume (PROCEDURE), Exercise Capacity Test (OTHER).
Who is sponsoring clinical trial NCT01783288?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01783288 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postural Tachycardia Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?
RECRUITING · NA
-
Autoimmune Basis for Postural Tachycardia Syndrome
RECRUITING · NA
-
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
ACTIVE NOT RECRUITING · NA
-
Acute Salt Handling in Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
-
fMRI in Postural Tachycardia Syndrome
ACTIVE NOT RECRUITING · NA
-
Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.